Advertisement

Der Beitrag der Biochemie zur Psychiatrischen Forschung und Therapie

  • P. C. Waldmeier
Conference paper

Zusammenfassung

Vorstellungen über die Materie, aus welcher das Gehirn besteht, und welchen Änderungen sie während dessen Funktion unterworfen sein könnte, gab es natürlich schon früh in der Geschichte der Menschheit, und im weitesten Sinne ist das Konzept einer chemischen Ursache von Geisteskrankheiten wohl so alt wie die Geschichte der Medizin. Eine wichtige Voraussetzung jedoch, dieses Konzept systematisch zu analysieren und zu konkretisieren, nämlich eine genauere Kenntnis der chemischen Zusammensetzung des Hirns, wurde erst mit dem Entstehen und der Entwicklung der organischen Chemie und ihren analytischen Techniken geschaffen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Blaschko H (1972) Catecholamines 1922–1971 (Chap.1). In: Eichler O, Farah A, Herken H, Welch AD (eds) Handb. exp. Pharmakol., Band XXXIII. Berlin, Springer pp 1–15Google Scholar
  2. Beckmann H, Goodwin FK (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients: clinical response to imipramine or amitriptyline. Arch gen Psychiat 32: 17–21PubMedCrossRefGoogle Scholar
  3. Bowers MB (1980) Biochemical processes in schizophrenia: an update. Schizophrenia Bull 6: 393–430Google Scholar
  4. Campbell JD (1953) Manic-depressive disease. Lippincott JB, PhiladelphiaGoogle Scholar
  5. Carlsson A, Lindquist M (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144CrossRefGoogle Scholar
  6. Erspamer V (ed) (1965) Handb. exp. Pharmacol. Band XIX. Springer, BerlinGoogle Scholar
  7. Flor-Henry P (1976) Lateralized temporal-limbic dysfunction und psychopathology. Ann N Y Acad Sci 280: 777–795PubMedCrossRefGoogle Scholar
  8. Garnett ES, Firnau G, Nahmias C, Lang AE, Ballinger McMaster J (1984) Intracerebral and quantitative measurement of intracerebral dopamine metabolism in health and disease. Clin Neuropharmacol 7 (Suppl.1): 530–531 (S 290)Google Scholar
  9. Garnett ES, Firnau G, Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature 305: 137–138PubMedCrossRefGoogle Scholar
  10. Garnett S, Firnau G, Nahmias C, Chirakal R (1983) Striatal dopamine metabolism in living monkeys examined by positron emission tomography. Brain Res: 280: 169–171PubMedCrossRefGoogle Scholar
  11. Hoffer A, Osmond H (1960) The chemical basis of clinical psychiatry. Thomas ChC, Springfield 111Google Scholar
  12. Horrobin DF (1977) Schizophrenia as a prostaglandin deficiency disease. Lancet I: 936–937CrossRefGoogle Scholar
  13. Kelwala S, Jones D, Sitaram N (1983) Monoamine metabolites as predictors of antidepressant response: a critique. Prog Neuro Psychopharmacol & Biol Psychiat 7: 229–240CrossRefGoogle Scholar
  14. Kety SS (1975) Biochemistry of the major psychoses (Chap.2.7). In: Freedman AM, Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry. Williams & Wilkins, Baltimore pp 178–187Google Scholar
  15. Lapin IP, Oxenkrug GF (1969) Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effort. Lancet I: 132–136CrossRefGoogle Scholar
  16. Lajtha A (ed) (1970) Handb. of Neurochemistry. Plenum Press, New YorkGoogle Scholar
  17. Mackay AV (1984) High dopamine in the left amygdala. Trends in Neurosci 7: 107–108CrossRefGoogle Scholar
  18. McIlwain H (1958) Chemical contributions, especially from the nineteenth century, to knowledge of the brain and its functioning. In: Poynter FN (ed) The brain and its functions. Blackwell Scientific Publications, Oxford, pp 167–186Google Scholar
  19. Muscettola G, Potter WZ, Pickar D, Goodwin, FK (1984) Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Arch gen Psychiat 41: 337–342PubMedCrossRefGoogle Scholar
  20. Pauling L (1968) Orthomolecular psychiatry. Science 160: 265 – 271PubMedCrossRefGoogle Scholar
  21. Phelps ME (1984) Principles of biochemical assays with positron CT. Clin Neuropharmacol 7 (Suppl 1): 520–521 (S285)Google Scholar
  22. Post RM, Uhde TW, Ballenger JC, Bunney WE (1982) Carbamazepine, temporal lobe epilepsy, and manic-depressive illness. In: Koella WP, Trimble MR (eds) Temporal lobe epilepsy, mania, and schizophrenia and the limbic system. Karger, Basel, pp 117–156Google Scholar
  23. Ragheb M, Ban TA (1982) Prostaglandins and schizophrenia: a review. Prog Neuro Psychopharmacol Biol Psychiat 6: 87–93CrossRefGoogle Scholar
  24. Reynolds GP (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305: 527–529PubMedCrossRefGoogle Scholar
  25. Rodnight R (1983) Schizophrenia: some current approaches. J Neurochem 41: 12–21PubMedCrossRefGoogle Scholar
  26. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence. Amer J Psychiat 122: 509–522PubMedGoogle Scholar
  27. Siever LJ, Uhde TW, Jimerson DC, Kafka MS, Lake CR, Targum S, Murphy DL (1983) Clinical studies of monoamine receptors in the affective disorders and receptor changes with antidepressant treatment. Prog Neuro Psychopharmacol Biol Psychiat 7:249–261CrossRefGoogle Scholar
  28. Smythies JR (1984) The transmethylation hypotheses of schizophrenia reevaluated. Trends in Neurosci 7:45–47CrossRefGoogle Scholar
  29. Stevens JR, Livermore A (1978) Kindling of the mesolimbic dopamine system: animal model of psychosis. Neurology 28: 36–46PubMedGoogle Scholar
  30. Swann AC, Maas JW, Hattox SE, Landis H (1980) Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. Life Sci 27: 1857–1862PubMedCrossRefGoogle Scholar
  31. Wagner HN, Burns HD, Dannais RF, et al. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221: 1264–1266PubMedCrossRefGoogle Scholar
  32. Wagner HN, Wong DF, Dannals RF, et al. (1984) Effect of age on dopamine receptors in the human brain. Clin Neuropharmacol 7 (Suppl 1): 540–541Google Scholar
  33. Wagner HN, Wong DF, Dannals RF, et al. (1984) Effect of age on dopamine receptors in the human brain. Clin Neuropharmacol 7 (Suppl 1): (S 296)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • P. C. Waldmeier

There are no affiliations available

Personalised recommendations